摘要
目的:建立超快速液相色谱-三重四极杆/线性离子阱质谱(UFLC-QTRAP-MS/MS)同时测定麦冬中甾体皂苷、高异黄酮、氨基酸及核苷类共32个成分含量的方法,考察不同加工方法对麦冬药材中多元活性成分的影响。方法:采用SynergiTM Hydro-RP 100?柱(2.0 mm×100 mm,2.5μm),以0.1%甲酸水溶液-0.1%甲酸乙腈溶液为流动相,梯度洗脱,流速0.4 mL·min-1,柱温30℃,多反应离子监测(MRM)模式检测;用灰色关联度分析(GRA)和TOPSIS方法对多元活性成分进行综合评价。结果:32个成分在一定浓度范围内线性关系良好,相关系数均大于0.999 0;精密度、重复性、稳定性良好,RSD均小于5%;平均加样回收率为97.4%~102.0%,RSD均小于5%。GRA和TOPSIS分析结果显示,S5、S6样品综合质量较好。结论:所建立的方法准确、可靠,可用于麦冬药材内在质量的综合评价,该研究可为麦冬适宜产地加工方法的优选及其加工方法的规范化和标准化提供基础资料。
Objective:To investigate the influence of different processing methods on components in Ophiopogonis Radix,and establish a comprehensive analytical method using UFLC-QTRAP-MS/MS for the simultaneous determination of thirty-two components including steroidal saponins,homoisoflavonoids,amino acids and nucleosides in Ophiopogonis Radix.Methods:The chromatographic separation was performed on a SynergiTM Hydro-RP 100?column(2.0 mm×100 mm,2.5μm)at 30℃with a gradient elution of 0.1%formic acid solution-0.1%aqueous formic acid at a flow rate of 0.4 mL·min-1.The components were detected under multiple-reaction monitoring(MRM)mode.Besides,grey relation analysis(GRA)and TOPSIS methods have been applied to comprehensively analyze and evaluate the results of multiple active constituents.Results:The results showed that thirty-two components had good linearity with correlation coefficients above 0.999 0.The method exhibited good precision,repeatability and stability with the relative standard deviations(RSDs)less than 5%,the average recoveries were between 97.4%and 102.0%with RSDs below 5%.In addition,the results of GRA and TOPSIS indicated that the quality of S5 and S6 was better.Conclusion:The established method is accurate and reliable,which can be used to appraise the quality of Ophiopogonis Radix.Our study may lay the way for the processing method of Ophiopogonis Radix in optimization,normalization and standardization.
作者
谈梦霞
陈佳丽
邹立思
刘训红
唐仁茂
马继梅
陈舒妤
石婧婧
陈江川
TAN Meng-xia;CHEN Jia-li;ZOU Li-si;LIU Xun-hong;TANG Ren-mao;MA Ji-mei;CHEN Shu-yu;SHI Jing-jing;CHEN Jiang-chuan(School of Pharmacy,Nanjing University of Chinese Medicine,Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine,Nanjing 210023,China;SZYY Group Pharmaceutical Limited,Taizhou 225500,China)
出处
《药物分析杂志》
CAS
CSCD
北大核心
2019年第6期992-1002,共11页
Chinese Journal of Pharmaceutical Analysis
基金
国家中药标准化项目(ZYBZH-C-JS-32)
江苏高校优势学科建设工程资助项目(YSXK-2014)
江苏高校品牌专业建设工程资助项目(PPZY2015A070)